<DOC>
	<DOCNO>NCT02538016</DOCNO>
	<brief_summary>The goal research project establish short-term use , tolvaptan safe potentially effective new therapy cystinuria , conduct short-term pilot study safety tolerability drug , assess impact urinary stone risk parameter , among adolescent young adult patient clinical cystinuria .</brief_summary>
	<brief_title>TCUPS- Tolvaptan Use Cyctinuria Urolithiasis : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Cystinuria</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>Males female age 12 25 year Weight â‰¥ 25kg ( 55 lb ) Confirmed cystinuria diagnosis Specific blood test level ( do within past 6 month ) Concurrent nonrenal disease might increase risk complication due aquaresis Liver biliary disease ( chronic acute ) Malabsorption syndrome gastrointestinal condition may interfere response therapy Noncutaneous malignancy within last 5 year History adverse reaction allergy Tolvaptan arginine vasopressin V2receptor antagonist</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cystinuria</keyword>
	<keyword>Kidney Stones</keyword>
</DOC>